CHRISTIN PAJUELO: Open Payments
NPI 1144962440 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 33 payments from 12 companies in 2025. Trend: 2023 $842 · 2024 $995 · 2025 $825
Food & beverage: $759Education: $66
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $167 |
| Mallinckrodt Hospital Products Inc. | 10 | $155 |
| CVRx, Inc. | 1 | $126 |
| Otsuka America Pharmaceutical, Inc. | 3 | $96 |
| OPKO Pharmaceuticals, LLC | 3 | $66 |
| Ardelyx, Inc. | 2 | $57 |
| Calliditas Therapeutics US Inc. | 2 | $56 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
| Renalytix AI, Inc. | 1 | $22 |
| Fresenius USA Marketing, Inc. | 1 | $19 |
Products named: FARXIGA, ACTHAR, Barostim Neo System, RAYALDEE, JYNARQUE, IBSRELA, TARPEYO, VOYXACT.
Industry payments across FL — which companies pay providers there.
